Home › Immuron Announces Statistically Significant Results of Triple-Action...
 

Keywords :   


Immuron Announces Statistically Significant Results of Triple-Action...

2016-01-12 18:22:08| Agriculture - Topix.net

Australian microbiome biopharmaceutical company Immuron Limited today announced that IMM-529, a first-in-class oral therapeutic, successfully demonstrated prevention of Clostridium difficile infection recurrence in over 77.8% of infected mice. The mouse model developed by Associate Professor Dena Lyras and her team at Monash University was designed to evaluate the effectiveness of IMM-529 when used in conjunction with standard of care antibiotic treatment.

Tags: results significant announces statistically

Category:Agriculture and Forestry

Latest from this category

All news
14.11Take a closer look at replacement female market
14.11Smithfield Foods responds to Minnesota Department of Labor and Industry settlement
14.11Is anyone keeping heifers?
14.11Cattle groups hail Thune as pick for Senate Majority Leader
14.11McDonalds, Syngenta and Lopez Foods aim to increase feed efficiency, reduce GHG emissions
14.11As holidays approach, ham demand, associated wholesale prices increasing
14.11Farm Progress announces return of Clint Peck to BEEF
14.11Contingency feed plans: Allows for wiggle room, ensures pigs stay healthy
Agriculture and Forestry »
15.112
15.11
15.11 RIDE THE 92 23-24
15.11
15.114m×4m
15.11FG/AG 25.0
15.11
15.11Edwards
More »